Chunji Gao Selected Research

Chunji Gao Research Topics

Disease

13	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2024 - 12/2013
9	Hematologic Neoplasms (Hematological Malignancy) 12/2023 - 01/2002
8	Neoplasms (Cancer) 12/2023 - 01/2013
7	Lymphoma (Lymphomas) 04/2024 - 02/2013
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2013
5	Bronchiolitis Obliterans Syndrome 10/2022 - 02/2015
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 01/2014
3	Leukemia 04/2024 - 02/2013
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 06/2019 - 01/2013
3	Multiple Myeloma 07/2013 - 12/2012
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2024 - 04/2024
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 01/2013
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 05/2019 - 07/2016
2	Neutropenia 01/2018 - 01/2015
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2015 - 04/2012
1	Eosinophilia 12/2023
1	Thrombotic Microangiopathies 06/2023
1	Hemorrhage 02/2022
1	Thrombocytopenia (Thrombopenia) 02/2022
1	Pathologic Processes 01/2022
1	Viremia 06/2019
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2018
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2018
1	Stomatitis 01/2015
1	Pain (Aches) 07/2014
1	Hematologic Diseases (Blood Diseases) 01/2014
1	Philadelphia Chromosome 01/2014
1	Hairy Cell Leukemia 01/2013
1	Blast Crisis (Blast Phase) 04/2012
1	T-Cell Lymphoma (Lymphoma, T Cell) 09/2011

Drug/Important Bio-Agent (IBA)

6	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 04/2024 - 02/2015
3	thymoglobulin FDA Link 10/2022 - 02/2015
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 06/2019
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 02/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 06/2015 - 02/2013
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2014 - 12/2013
2	Bendamustine Hydrochloride FDA Link 07/2013 - 01/2013
1	MagnesiumIBA 12/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023
1	AclarubicinIBA 01/2023
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2023
1	eltrombopag FDA Link 02/2022
1	N-methyladenosineIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2021
1	ruxolitinibIBA 01/2021
1	Decitabine FDA Link 01/2021
1	Phosphotransferases (Kinase)IBA 01/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	Sirolimus (Rapamycin)FDA Link 09/2015
1	SB 743921IBA 06/2015
1	Imatinib Mesylate (Gleevec)FDA Link 06/2015
1	KinesinsIBA 06/2015
1	Itraconazole (Sporanox)FDA LinkGeneric 01/2015
1	Voriconazole (Vfend)FDA LinkGeneric 01/2015
1	Caspofungin (Cancidas)FDA Link 01/2015
1	Tyrosine Kinase InhibitorsIBA 01/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 07/2013
1	entinostat (MS 275)IBA 07/2013
1	UbiquitinIBA 02/2013
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2013
1	Cladribine FDA LinkGeneric 01/2013
1	Purine NucleosidesIBA 01/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2013
1	isocitric acid (isocitrate)IBA 01/2013
1	Bortezomib (Velcade)FDA Link 12/2012
1	Melphalan (Alkeran)FDA LinkGeneric 12/2012

Therapy/Procedure

22	Hematopoietic Stem Cell Transplantation 04/2024 - 04/2012
10	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2022 - 06/2012
8	Stem Cell Transplantation 01/2023 - 01/2002
7	Therapeutics 12/2023 - 12/2012
6	Drug Therapy (Chemotherapy) 04/2024 - 01/2015
4	Transplantation 10/2022 - 06/2012
1	Plasma Exchange 06/2023
1	Induction Chemotherapy 01/2021
1	Cell Transplantation 06/2018
1	Salvage Therapy 01/2018
1	Cryotherapy (Therapy, Cold) 01/2015
1	Length of Stay 07/2014
1	Organ Transplantation 01/2014
1	Chemoradiotherapy 09/2011